USEFULNESS OF FIB-4 INDEX AND ALT AT 1 YEAR OF NUCLEOS(T) IDE ANALOG TREATMENT FOR PREDICTION OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS

被引：0
|
作者：
Inoue, Jun [1 ]
Akahane, Takehiro [2 ]
Kobayashi, Tomoo [3 ]
Kimura, Osamu [4 ]
Sato, Kosuke [1 ]
Ninomiya, Masashi [1 ]
Iwata, Tomoaki [1 ]
Takai, Satoshi [5 ]
Kisara, Norihiro [6 ]
Sato, Toshihiro [7 ]
Nagasaki, Futoshi [8 ]
Miura, Masahito [9 ]
Nakamura, Takuya [10 ]
Umetsu, Teruyuki [11 ]
Sano, Akitoshi [1 ]
Tsuruoka, Mio [1 ]
Onuki, Masazumi [1 ]
Sawahashi, Satoko [1 ]
Niitsuma, Hirofumi [1 ]
Masamune, Atsushi [1 ]
机构：
[1] Tohoku Univ, Grad Sch Med, Sendai, Miyagi, Japan
[2] Japanese Red Cross Ishinomaki Hosp, Ishinomaki, Miyagi, Japan
[3] Tohoku Rosai Hosp, Sendai, Miyagi, Japan
[4] South Miyagi Med Ctr, Sendai, Miyagi, Japan
[5] Iwaki City Med Ctr, Iwaki, Fukushima, Japan
[6] Japan Community Hlth Care Org Sendai South Hosp, Sendai, Miyagi, Japan
[7] LC Clin, Sendai, Miyagi, Japan
[8] Sendai City Hosp, Sendai, Miyagi, Japan
[9] Omagari Kousei Med Ctr, Daisen, Akita, Japan
[10] Yamagata City Hosp Saiseikan, Yamagata, Japan
[11] Kesennuma City Hosp, Kesennuma, Miyagi, Japan
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1450-C
引用
收藏
页码：S550 / S550
页数：1
相关论文
共 50 条
  • [1] Usefulness of the Fibrosis-4 index and alanine aminotransferase at 1 year of nucleos(t)ide analog treatment for prediction of hepatocellular carcinoma in chronic hepatitis B patients
    Inoue, Jun
    Akahane, Takehiro
    Kobayashi, Tomoo
    Kimura, Osamu
    Sato, Kosuke
    Ninomiya, Masashi
    Iwata, Tomoaki
    Takai, Satoshi
    Kisara, Norihiro
    Sato, Toshihiro
    Nagasaki, Futoshi
    Miura, Masahito
    Nakamura, Takuya
    Umetsu, Teruyuki
    Sano, Akitoshi
    Tsuruoka, Mio
    Onuki, Masazumi
    Sawahashi, Satoko
    Niitsuma, Hirofumi
    Masamune, Atsushi
    HEPATOLOGY RESEARCH, 2024, 54 (02) : 131 - 141
  • [2] FIB-4 index and serum α-fetoprotein are useful predictors of hepatocellular carcinoma occurrence in hepatitis B patients with nucleos(t)ide analogs therapy
    Kuwano, Akifumi
    Miyazaki, Masayuki
    Yada, Masayoshi
    Tanaka, Kosuke
    Koga, Yuta
    Masumoto, Akihide
    Motomura, Kenta
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (03)
  • [3] Baseline Circulating miR-125b Levels Predict a High FIB-4 Index Score in Chronic Hepatitis B Patients after Nucleos(t)ide Analog Treatment
    Wu, Jyun-Yi
    Tsai, Yi-Shan
    Li, Chia-Chen
    Yeh, Ming-Lun
    Huang, Ching-, I
    Huang, Chung-Feng
    Hsu, Jia-Ning
    Hsieh, Meng-Hsuan
    Chen, Yo-Chia
    Liu, Ta-Wei
    Lin, Yi-Hung
    Liang, Po-Cheng
    Lin, Zu-Yau
    Chuang, Wan-Long
    Yu, Ming-Lung
    Dai, Chia-Yen
    BIOMEDICINES, 2022, 10 (11)
  • [4] Poor improvement of on-treatment FIB-4 index after initiation of nucleos(t)ide analogs is associated with development of hepatocellular carcinoma in both cirrhotic and non-cirrhotic chronic hepatitis B patients
    Murakawa, Miyako
    Shimizu, Taro
    Takeichi, Eiko
    Tsuchiya, Jun
    Sato, Ayako
    Miyoshi, Masato
    Kawai-Kitahata, Fukiko
    Nitta, Sayuri
    Itsui, Yasuhiro
    Nakagawa, Mina
    Azuma, Seishin
    Kakinuma, Sei
    Asahina, Yasuhiro
    JOURNAL OF HEPATOLOGY, 2020, 73 : S592 - S593
  • [5] FIB-4, not APRI predicts the regression of fibrosis in chronic hepatitis B patients treated with nucleos(t)ide analogs.
    Kapuria, Devika
    Surana, Pallavi
    Ben-Yakov, Gil S.
    Heller, Theo
    Liang, T. Jake
    Hoofnagle, Jay H.
    Takyar, Varun K.
    Kleiner, David E.
    Koh, Christopher
    HEPATOLOGY, 2017, 66 : 1027A - 1027A
  • [6] Risk factors for hepatocellular carcinoma at baseline and 1 year after initiation of nucleos(t)ide analog therapy for chronic hepatitis B
    Kaneko, Shun
    Kurosaki, Masayuki
    Mashiba, Toshie
    Marusawa, Hiroyuki
    Kondo, Masahiko
    Kojima, Yuji
    Uchida, Yasushi
    Fujii, Hideki
    Akahane, Takehiro
    Yagisawa, Hitoshi
    Kusakabe, Atsunori
    Kobashi, Haruhiko
    Abe, Takehiko
    Yoshida, Hideo
    Ogawa, Chikara
    Furuta, Koichiro
    Tamaki, Nobuharu
    Tsuji, Keiji
    Matsushita, Tomomichi
    Izumi, Namiki
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (01)
  • [7] Noninvasive prediction of hepatocellular carcinoma development using the FIB-4 index in chronic hepatitis C patients
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Yasui, Yutaka
    Suzuki, Shoko
    Hosokawa, Takanori
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Itakura, Jun
    Izumi, Namiki
    HEPATOLOGY, 2013, 58 : 1272A - 1273A
  • [8] Utility of Prediction Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Treated with Nucleos(t)ide Analogues
    Tawada, Akinobu
    Chiba, Tetsuhiro
    Saito, Tomoko
    Ogasawara, Sadahida
    Suzuki, Eiichiro
    Ooka, Yoshihiko
    Arai, Makoto
    Kanda, Tatsuo
    Shinozaki, Masami
    Goto, Nobuaki
    Nagashima, Kengo
    Yokosuka, Osamu
    ONCOLOGY, 2016, 90 (04) : 199 - 208
  • [9] Impact of FIB-4 index on hepatocellular carcinoma incidence during nucleos(t)ide analogue therapy in patients with chronic hepatitis B: An analysis using time-dependent receiver operating characteristic
    Tada, Toshifumi
    Kumada, Takashi
    Toyoda, Hidenori
    Tsuji, Kunihiko
    Hiraoka, Atsushi
    Tanaka, Junko
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (02) : 451 - 458
  • [10] Aspirin Reduces the Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Oral Nucleos(t)ide Analog
    Hui, Vicki Wing-Ki
    Yip, Terry Cheuk-Fung
    Wong, Vincent Wai-Sun
    Tse, Yee-Kit
    Chan, Henry Lik-Yuen
    Lui, Grace Chung-Yan
    Wong, Grace Lai-Hung
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (03) : e00324
12345